Development of a screening tool to identify patients likely to benefit from clinical pharmacist review in a home-based primary care population.
Journal
Journal of the American Pharmacists Association : JAPhA
ISSN: 1544-3450
Titre abrégé: J Am Pharm Assoc (2003)
Pays: United States
ID NLM: 101176252
Informations de publication
Date de publication:
Historique:
received:
23
11
2019
revised:
24
02
2020
accepted:
08
03
2020
pubmed:
3
6
2020
medline:
29
6
2021
entrez:
3
6
2020
Statut:
ppublish
Résumé
To create a novel screening tool that identified patients who were most likely to benefit from pharmacist in-home medication reviews. Single-center, retrospective study. A total of 25 homebound patients in Forsyth County, NC, aged 60 years or older with physical or cognitive impairments and enrolled in home-based primary care or transitional and supportive care programs participated in the study. Pharmacy resident-provider pairs conducted home visits for all patients in the study. Pharmacy residents assessed the subjective risk (high, medium, low) of medication nonadherence using information obtained from home visits (health literacy, support network, medications, and detection of something unexpected related to medications). An electronic medical record-based risk score was simultaneously calculated using screening tool components (i.e., electronic frailty index score, LACE+ index [length of stay in the hospital, acuity of admission, comorbidity, emergency department utilization in the 6 months before admission], and 2015 American Geriatric Society Beers Criteria). The electronic medical record-based screening tool numerical risk scores were compared with pharmacy resident subjective risk assessments using tree-based classification models to determine screening tool components that best predicted pharmacy residents' subjective assessment of patients' likelihood of benefit from in-home pharmacist medication review. Following the study, satisfaction surveys were given to providers and pharmacy residents. The best predictor of high-risk patients was an electronic frailty index score greater than 0.32 (indicating very frail) or LACE+ index greater than or equal to 59 (at high risk for hospital readmission). Pharmacy residents and providers agreed that homebound patients at high-risk for medication noncompliance benefited from pharmacist time and attention in home visits. In homebound older persons, this screening tool allowed for the identification of patients at high-risk for medication nonadherence through targeted in-home pharmacist medication reviews. Further studies are needed to validate the accuracy of this tool internally and externally.
Identifiants
pubmed: 32482500
pii: S1544-3191(20)30122-9
doi: 10.1016/j.japh.2020.03.008
pmc: PMC8867744
mid: NIHMS1778682
pii:
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
750-756Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001420
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier Inc.
Références
Hypertension. 2015 Dec;66(6):1145-51
pubmed: 26527048
Am J Health Syst Pharm. 2018 Jul 15;75(14):1039-1047
pubmed: 29789318
JAMA Intern Med. 2015 Jul;175(7):1180-6
pubmed: 26010119
Ann Pharmacother. 2004 Jun;38(6):1048-52
pubmed: 15113983
Age Ageing. 2016 May;45(3):353-60
pubmed: 26944937
J Manag Care Spec Pharm. 2017 Mar;23(3):318-326
pubmed: 28230459
Dan Med J. 2016 Sep;63(9):
pubmed: 27585531
J Am Geriatr Soc. 2015 Nov;63(11):2227-46
pubmed: 26446832
J Am Geriatr Soc. 2014 Dec;62(12):2243-51
pubmed: 25371236
BMJ Open. 2017 Jul 13;7(7):e016921
pubmed: 28710226
J Am Med Dir Assoc. 2014 Sep;15(9):635-42
pubmed: 24746590
J Geriatr Cardiol. 2018 Feb;15(2):153-161
pubmed: 29662509
Clin Geriatr Med. 2009 Feb;25(1):149-54, viii-ix
pubmed: 19217499
J Gerontol A Biol Sci Med Sci. 2019 Oct 4;74(11):1771-1777
pubmed: 30668637